BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 20177669)

  • 1. Novel biochemical pathways for 5-Fluorouracil in managing experimental hepatocellular carcinoma in rats.
    Abdel-Hamid NM; Morsy MA
    J Membr Biol; 2010 Mar; 234(1):29-34. PubMed ID: 20177669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Premalignant variations in extracellular matrix composition in chemically induced hepatocellular carcinoma in rats.
    Abdel-Hamid NM
    J Membr Biol; 2009 Aug; 230(3):155-62. PubMed ID: 19688284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A suggested guiding panel of seromarkers for efficient discrimination between primary and secondary human hepatocarcinoma.
    Abdel-Hamid NM; Abouzied MM; Nazmy MH; Fawzy MA; Gerges AS
    Tumour Biol; 2016 Feb; 37(2):2539-46. PubMed ID: 26386723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Galactosylated chitosan/5-fluorouracil nanoparticles inhibit mouse hepatic cancer growth and its side effects.
    Cheng MR; Li Q; Wan T; He B; Han J; Chen HX; Yang FX; Wang W; Xu HZ; Ye T; Zha BB
    World J Gastroenterol; 2012 Nov; 18(42):6076-87. PubMed ID: 23155336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ellagic Acid Holds Promise Against Hepatocellular Carcinoma in an Experimental Model: Mechanisms of Action.
    Zaazaa AM; Lokman MS; Shalby AB; Ahmed HH; El-Toumy SA
    Asian Pac J Cancer Prev; 2018 Feb; 19(2):387-393. PubMed ID: 29479987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin D potentiates anti-tumor activity of 5-fluorouracil via modulating caspase-3 and TGF-β1 expression in hepatocellular carcinoma-induced in rats.
    R Ebrahim A; El-Mesery M; El-Karef A; Eissa LA
    Can J Physiol Pharmacol; 2018 Dec; 96(12):1218-1225. PubMed ID: 30205014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of Rumex vesicarius as anticancer remedy against hepatocellular carcinoma: a proposal-based on experimental animal studies.
    Shahat AA; Alsaid MS; Kotob SE; Ahmed HH
    Asian Pac J Cancer Prev; 2015; 16(10):4303-10. PubMed ID: 26028090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic effect of coenzyme Q10 against experimentally-induced hepatocellular carcinoma in rats.
    Fouad AA; Al-Mulhim AS; Jresat I
    Environ Toxicol Pharmacol; 2013 Jan; 35(1):100-8. PubMed ID: 23274416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Combination of Arginine Deprivation and 5-Fluorouracil Improves Therapeutic Efficacy in Argininosuccinate Synthetase Negative Hepatocellular Carcinoma.
    Thongkum A; Wu C; Li YY; Wangpaichitr M; Navasumrit P; Parnlob V; Sricharunrat T; Bhudhisawasdi V; Ruchirawat M; Savaraj N
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28587170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocyte Lysosomal Membrane Stabilization by Olive Leaves against Chemically Induced Hepatocellular Neoplasia in Rats.
    Abdel-Hamid NM; El-Moselhy MA; El-Baz A
    Int J Hepatol; 2011; 2011():736581. PubMed ID: 21994869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiproliferative effects of 5-fluorouracil and interferon-alpha in combination on a hepatocellular carcinoma cell line in vitro and in vivo.
    Kojiro S; Yano H; Ogasawara S; Momosaki S; Takemoto Y; Nishida N; Kojiro M
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):129-37. PubMed ID: 16706824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoteichoic acid of Bifidobacterium in combination with 5-fluorouracil inhibit tumor growth and relieve the immunosuppression.
    Xie N; Wang Y; Wang Q; Li FR; Guo B
    Bull Cancer; 2012 May; 99(5):E55-63. PubMed ID: 22522606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical modulation of the catabolism and tissue uptake of the anticancer drug 5-fluorouracil by 5-bromovinyluracil: assessment with metabolic (19)F MR imaging.
    Brix G; Bellemann ME; Haberkorn U
    Magn Reson Med; 1999 Nov; 42(5):936-43. PubMed ID: 10542353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of calmodulin antagonist berbaminederivative-EBB on hepatoma in vitro and in vivo.
    Liu J; Qi S; Zhu H; Zhang J; Li Z; Wang T
    Chin Med J (Engl); 2002 May; 115(5):759-62. PubMed ID: 12133551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suramin inhibits hepatic tissue damage in hepatocellular carcinoma through deactivation of heparanase enzyme.
    Tayel A; Abd El Galil KH; Ebrahim MA; Ibrahim AS; El-Gayar AM; Al-Gayyar MM
    Eur J Pharmacol; 2014 Apr; 728():151-60. PubMed ID: 24530413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The mechanism of potentiation of the antitumor effect of 5-fluorouracil by methionine-free intravenous amino acid solution (AO-90) in rats].
    Hibino Y; Kawarabayashi Y; Kohri H; Ueda N; Tsukagoshi S
    Gan To Kagaku Ryoho; 1994 Sep; 21(12):2021-8. PubMed ID: 8085853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical modulation of intraperitoneal fluorouracil by allopurinol-the effect on an experimental adenocarcinoma in the liver.
    Lindnér P; Carlsson G; Gustavsson B; Holmberg SB; Naredi P; Peterson A; Hafström L
    Anticancer Res; 1994; 14(3A):847-52. PubMed ID: 8074485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RBFOX3 Regulates the Chemosensitivity of Cancer Cells to 5-Fluorouracil via the PI3K/AKT, EMT and Cytochrome-C/Caspase Pathways.
    Liu T; Wu X; Li Y; Lu W; Zheng F; Zhang C; Long Q; Qiu H; Li Y; Ge Q; Chen M; Yu X; Chen W; Zhang H; Huang W; Luo M; Deng W; Li L
    Cell Physiol Biochem; 2018; 46(4):1365-1380. PubMed ID: 29689552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of moxibustion at "Ganshu" (BL 18) on serum alpha-fatoprotein and liver livin levels in rats with precancerous lesion of primary hepatocellular carcinoma].
    Jia WR; Dong F; Xie XL; Wang P; Zhang QJ; Wang YQ; Hou ZW; Sui MH
    Zhen Ci Yan Jiu; 2014 Jun; 39(3):211-5. PubMed ID: 25069198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficient chemosensitizing and antimetastatic combinations of a naturally occurring trans-ferulic acid with different chemotherapies on an in vitro hepatocellular carcinoma model.
    Abdel-Hamid NM; ElNakeeb NA; El-Senduny FF
    Naunyn Schmiedebergs Arch Pharmacol; 2023 Aug; 396(8):1741-1747. PubMed ID: 36811666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.